Mephedrone use is increasing in London

Lancet. 2016 Apr 23;387(10029):1719-20. doi: 10.1016/S0140-6736(16)30258-6.

Authors

Joanna Hockenhull¹, Kevin G Murphy², Sue Paterson³

Affiliations

¹ Toxicology Unit, Imperial College London, Charing Cross Hospital, London W6 8RP, UK. Electronic address: j.hockenhull@imperial.ac.uk.
² Section of Endocrinology and Investigative Medicine, Imperial College London, Hammersmith Hospital, London, UK.
³ Toxicology Unit, Imperial College London, Charing Cross Hospital, London W6 8RP, UK.

PMID: 27116276
DOI: 10.1016/S0140-6736(16)30258-6

No abstract available

Publication types

Letter

MeSH terms

Humans
Illicit Drugs*
London / epidemiology
Methamphetamine / analogs & derivatives*
Substance-Related Disorders / epidemiology*

Substances

Illicit Drugs
Methamphetamine
mephedrone